September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence ...
September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...
September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...
The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...
September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...
In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...
September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease ...
September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...
September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing ...
September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically ...
September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...